AbbVie earnings

Next report

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Oct 31, 2025 and Oct 30, 2024, before the open.

Who else reports that week: the earnings calendar.

Last report: Jul 31, 2026, 07:51 ET (before the open). The filing on SEC EDGAR ↗

Across the last 4 reports we hold closes for, the first close moved a median 3.46% either way. Up 1 of 4.

Moves are only shown for reports where we hold closing prices.

1. Jul 31, 202607:51 ET · before the open8-K ↗−2.51%1D
2. Apr 29, 202607:50 ET · before the open8-K ↗+3.14%1D
3. Feb 4, 202607:54 ET · before the open8-K ↗−3.79%1D
4. Oct 31, 202507:51 ET · before the open8-K ↗−4.45%1D
5. Jul 31, 202507:48 ET · before the open8-K ↗no price data1D
6. Apr 25, 202507:48 ET · before the open8-K ↗no price data1D
7. Jan 31, 202507:42 ET · before the open8-K ↗no price data1D
8. Oct 30, 202407:43 ET · before the open8-K ↗no price data1D

Move = the first close after the release against the close before it. A release after 4pm ET is priced by the next session; one before 9:30am ET by that day’s. Times are when the SEC accepted the 8-K (Item 2.02), which follows the press release by minutes. Closes held from Sep 2, 2025; “no price data” means we don't hold the closes for that report. 8 other Item 2.02 filings, filed weeks ahead of a report (a delivery or preliminary update), are not counted as reports. Prior-session closes only; not a forecast, not advice.